US Patent Issued to SPIRIFY PHARMA on June 16 for "Hydroxynorketamine analogues, compositions comprising same and methods of use thereof" (District Of Columbia Inventor)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,655,089, issued on June 16, was assigned to SPIRIFY PHARMA INC. (Naples, Fla.).

"Hydroxynorketamine analogues, compositions comprising same and methods of use thereof" was invented by Irving William Wainer (Washington).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure pertains to amino cyclohexanone compounds, pharmaceutical compositions containing same and methods of treating depression, pain, inflammation, and other clinical indications."

The patent was filed on June 16, 2021, under Application No. 18/010,249.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sec...